Cite
HARVARD Citation
Azzi, G. et al. (n.d.). 25 Line of therapy adjustment in a patient with advanced triple-negative breast cancer (TNBC) by using personalized ctDNA test for treatment response monitoring. Journal for immunotherapy of cancer. pp. A13-A14. [Online].